advertisement
 |
|
|
Top Stories
A $1.7-billion acquisition of CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.
/ read more /
The agency has published a Q&A document to answer questions about what EMA is doing to prevent medicine shortages during Brexit.
/ read more /
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
advertisement
 |
|
|
INTERPHEX 2019 KEYNOTE SERIES
Bioprocessing Capacity Challenges
How is the industry meeting capacity demands for biologic-based drugs? Experts discuss ways to address production-related challenges.
LEARN MORE
|
|
advertisement
 |
|
|
Industry News
Researchers at the Georgia Institute of Technology developed a technique for administering contraceptive hormones through 'pharmaceutical jewelry'.
/ read more /
Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.
/ read more /
More Industry News
|
|
|
advertisement
 |
|
Supplier News
Alcami Biologics formed to meet market demands for biological drug development services.
/ read more /
Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
/ read more /
More Supplier News
|
|
|
advertisement
 |
|
Bio/Pharma News
Merck KGaA opened a collaborative bio/pharma development facility in Molsheim, France and announced an investment plan through 2025 for its Darmstadt, Germany headquarters.
/ read more /
Worth up to $605 million, the collaboration will focus on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases.
/ read more /
More Bio/Pharma News
|
|
|
advertisement
 |
|
advertisement
Exclusive Interview from AAPS 2018
Cutting Edge Formulations in Topic Drug Development
 Watch Video |
|
|
Regulatory News
The guidance provides nonclinical and clinical recommendations to sponsors for the development of products for the prevention of HIV-1 infection.
/ read more /
|
|
|
|
The guidance provides industry with information on the design and implementation of natural history studies to support the development of treatments for rare diseases.
/ read more /
More Regulatory News
|
|
|
advertisement
The pharma industry – defined.
Experience the long-standing expertise of CPhI with the convergence of pharma's most motivated buyers, experienced sellers, in addition to an array of networking opportunities at CPhI North America – happening April 30 – May 2, 2019 in Chicago, Illinois. Register now to walk our strategically zoned Expo Hall for free!
 Click here to register for free. |
|
|
|
|
ANALYTICS
Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.
/ read more /
|
|
|
|
DOSAGE FORMS
Containment valves and smart monitoring can keep employees safe and improve manufacturing efficiency when handling potent APIs, intermediates, and solid-dosage drugs.
/ read more /
|
|
|
|
|
EXCIPIENTS
Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.
/ read more /
|
|
|
TAKE THE SURVEY
Biopharmaceutical Manufacturing Survey
Participate in BioPlan's 16th Annual Global Biopharmaceutical Manufacturing Study. Share your insight on current global and regional trends affecting biomanufacturing and receive a free aggregated summary of this year's results and an updated Top Trends in Biopharmaceutical Manufacturing White Paper. If you complete, the survey, BioPlan will donate $15 (up to $3000) on your behalf to global health charities or you can receive a $15 Amazon e-gift card.
Take the survey
|
|
Events
April 2–4, 2019
April 14–17, 2019
April 30–May 2, 2019
more events |
|
|
eBOOKS
 |
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing. |
|
|
|
|
|
